Last Updated: June 22, 2026

VALBENAZINE Drug Patent Profile

Name: VALBENAZINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Valbenazine patents expire, and when can generic versions of Valbenazine launch?

Valbenazine is a drug marketed by Lupin and Zydus Lifesciences and is included in two NDAs.

The generic ingredient in VALBENAZINE is valbenazine tosylate. One supplier is listed for this compound. Additional details are available on the valbenazine tosylate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Valbenazine

A generic version of VALBENAZINE was approved as valbenazine tosylate by LUPIN on April 5^th, 2024.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for VALBENAZINE?
What are the global sales for VALBENAZINE?
What is Average Wholesale Price for VALBENAZINE?

Summary for VALBENAZINE

US Patents:	0
Applicants:	2
NDAs:	2
DailyMed Link:	VALBENAZINE at DailyMed

Drug patent expirations by year for VALBENAZINE

US Patents and Regulatory Information for VALBENAZINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin	VALBENAZINE TOSYLATE	valbenazine tosylate	CAPSULE;ORAL	216064-001	Apr 5, 2024	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Zydus Lifesciences	VALBENAZINE TOSYLATE	valbenazine tosylate	CAPSULE;ORAL	216137-002	Aug 7, 2024		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Lupin	VALBENAZINE TOSYLATE	valbenazine tosylate	CAPSULE;ORAL	216064-002	Apr 5, 2024	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for VALBENAZINE

Generic valbenazine launch date?
Valbenazine vs deutetrabenazine?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.